← Leaderboards
John Gerard Doench
Harvard Medical School
$3,730,510
Attributed
$3,730,510
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2017–22$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,730,510 · 3
By mechanism
U01$2,367,370 · 1
U19$923,140 · 1
R21$440,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Arlene H Sharpe$68,359,602
- Norbert Perrimon$95,273,017
- Min Dong$19,640,842
- Leon Peshkin$6,585,278
- Marc W Kirschner$55,400,682
Others in their field
Other Emerging Leaders on “Libraries”
- Leonard Freedman · Leidos Biomedical Research, Inc.$792,858,643
- Lynn Briscoe · Leidos Biomedical Research, Inc.$225,263,761
- Leonard Freedmand · Leidos Biomedical Research, Inc.$160,413,316
- Jean Macdonald · Dana-Farber Cancer Inst$26,990,229
- Bruce Blough · Research Triangle Institute$19,637,160
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$19,237,129
Research focus
LibrariesPhenotypeResourcesCrispr ScreenVectorScreeningCrispr/Cas TechnologyExperimental StudyGenetic ScreeningCellsIn VivoMediatingEnsureGenerationsComplexGuide RnaReagentBioinformaticsInterestInsightGenomeGene FunctionGenesGenomic Dna
Grant awards (9)
Advanced tools for HCMI model genetic perturbation and metastasis characterization$787,646
U01 · FY2022 · CA · contact PI
Advanced tools for HCMI model genetic perturbation and metastasis characterization$789,862
U01 · FY2021 · CA · contact PI
Core C: Defining regulators of immunity to acute infection using CRISPR screens$362,507
U19 · FY2021 · AI · contact PI
Advanced tools for HCMI model genetic perturbation and metastasis characterization$789,862
U01 · FY2020 · CA · contact PI
CRISPR screens for SARS-CoV-2 Host Factors$440,000
R21 · FY2020 · AI · contact PI
Core C: Defining regulators of immunity to acute infection using CRISPR screens$148,352
U19 · FY2020 · AI · contact PI
Core C: Defining regulators of immunity to acute infection using CRISPR screens$127,002
U19 · FY2019 · AI · contact PI
Core C: Defining regulators of immunity to acute infection using CRISPR screens$140,902
U19 · FY2018 · AI · contact PI
Core C: Defining regulators of immunity to acute infection using CRISPR screens$144,377
U19 · FY2017 · AI · contact PI